Rothschild & CO Asset Management Us Inc. Horizon Therapeutics Public LTD CO Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 403,734 shares of HZNP stock, worth $0. This represents 0.7% of its overall portfolio holdings.

Number of Shares

403,734

Previous 428,706 5.82%

Holding current value

Previous $26.5 Million 73.16%

% of portfolio

0.7%

Previous 0.45%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $1.56 Million - $2.84 Million	-24,972 Reduced 5.82%	403,734 $45.9 Million
Q3 2022 Nov 07, 2022	SELL	$58.92 - $84.67 $808,677 - $1.16 Million	-13,725 Reduced 3.1%	428,706 $26.5 Million
Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $1.61 Million - $2.36 Million	20,248 Added 4.8%	442,431 $35.3 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $13.5 Million - $17.2 Million	156,549 Added 58.93%	422,183 $44.4 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $268,871 - $327,114	-2,728 Reduced 1.02%	265,634 $28.6 Million

Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $1.69 Million - $2.03 Million	-18,401 Reduced 6.42%	268,362 $29.4 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $12.3 Million - $13.7 Million	-142,901 Reduced 33.26%	286,763 $26.9 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $12.7 Million - $16.9 Million	-176,681 Reduced 29.14%	429,664 $39.5 Million
Q4 2020 Feb 08, 2021	SELL	$67.0 - $84.39 $8.65 Million - $10.9 Million	-129,104 Reduced 17.55%	606,345 $44.4 Million
Q3 2020 Nov 09, 2020	SELL	$55.23 - $79.93 $9 Million - $13 Million	-162,964 Reduced 18.14%	735,449 $57.1 Million
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $16.2 Million - $30.6 Million	-537,821 Reduced 37.45%	898,413 $49.9 Million
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $6.67 Million - $10.3 Million	-268,367 Reduced 15.74%	1,436,234 $42.5 Million
Q4 2019 Feb 12, 2020	SELL	$25.43 - $36.67 $4.24 Million - $6.12 Million	-166,811 Reduced 8.91%	1,704,601 $61.7 Million
Q3 2019 Nov 08, 2019	BUY	$23.0 - $27.97 $4 Million - $4.86 Million	173,738 Added 10.23%	1,871,412 $51 Million
Q2 2019 Jul 25, 2019	BUY	$22.81 - $28.48 $38.7 Million - $48.3 Million	1,697,674 New	1,697,674 $40.8 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Horizon Therapeutics Public LTD CO Transaction History